In the context of neurotransmission, what does an SSRI do?

In the context of neurotransmission, what does an SSRI do?

• A. Increases serotonin production
• B. Blocks serotonin reuptake into the presynaptic neuron
• C. Augments serotonin receptor sensitivity
• D. Stimulates the breakdown of serotonin

Answer: (B)

Selective serotonin reuptake inhibitors (SSRIs) are a class of medications primarily used to treat depression and anxiety disorders. The therapeutic mechanism of SSRIs revolves around their ability to block the reuptake of serotonin into the presynaptic neuron. When serotonin is released into the synaptic cleft, it binds to serotonin receptors on the postsynaptic neuron, leading to its neurotransmitter effects. Post-synaptic receptors help in the transmission of the neural signal. After this interaction, serotonin is typically reabsorbed by the presynaptic neuron through specialized transporters, a process known as reuptake. By inhibiting this reuptake process, SSRIs increase the availability of serotonin in the synaptic cleft. This increased presence of serotonin enhances neurotransmission and is associated with improved mood and reduced anxiety in patients. Therefore, the function of SSRIs in preventing serotonin from being reabsorbed is crucial for their antidepressant and anxiolytic effects. This action is what distinguishes SSRIs from other types of medications targeting serotonin, which may increase production or modify receptor sensitivity differently.

Selective serotonin reuptake inhibitors (SSRIs) are a class of medications primarily used to treat depression and anxiety disorders. The therapeutic mechanism of SSRIs revolves around their ability to block the reuptake of serotonin into the presynaptic neuron.

When serotonin is released into the synaptic cleft, it binds to serotonin receptors on the postsynaptic neuron, leading to its neurotransmitter effects. Post-synaptic receptors help in the transmission of the neural signal. After this interaction, serotonin is typically reabsorbed by the presynaptic neuron through specialized transporters, a process known as reuptake. By inhibiting this reuptake process, SSRIs increase the availability of serotonin in the synaptic cleft.

This increased presence of serotonin enhances neurotransmission and is associated with improved mood and reduced anxiety in patients. Therefore, the function of SSRIs in preventing serotonin from being reabsorbed is crucial for their antidepressant and anxiolytic effects. This action is what distinguishes SSRIs from other types of medications targeting serotonin, which may increase production or modify receptor sensitivity differently.